In new TV ads, Pfizer is tackling two key concerns brought on by the COVID-19 pandemic. The first […]
Novartis is looking to grow its new multiple sclerosis drug Mayzent in a crowded field, and with Gilenya generics threatening, the newer MS medicine may need […]
Salisbury asks what we might learn from the covid-19 pandemic.1 At times like this, we have to make […]
bmj;369/apr21_23/m1604/FAF1faDavid William Young was consultant physician at Dudley Road Hospital (now City Hospital) in Birmingham from 1974 to […]
bmj;369/apr21_22/m1603/FAF1faBorn in Dar Es Salam, Tanzania, where his parents had moved from Goa in India, Michael Joseph Noronha […]
bmj;369/apr21_21/m1431/FAF1faMalcolm Keith Sykes was one of the most prominent British anaesthetists of the second half of the 20th […]
AbstractObjectiveTo evaluate viral loads at different stages of disease progression in patients infected with the 2019 severe acute […]
Americans have been told daily—by politicians, by experts, by the media—that researchers are urgently working on COVID-19 vaccines, and […]
Merck KGaA and subsidiary MilliporeSigma made a big bet on gene therapy by expanding their viral vector manufacturing […]
Between a huge Alzheimer’s drug setback last spring, its resurrection in the fall and a COVID-19 “superspreader” meeting […]